Human CAR NK cells: A new non-viral method allowing high efficient transfection and strong tumor cell killing

T. Ingegnere; F. R. Mariotti; A. Pelosi; C. Quintarelli; Angelis B. De; N. Tumino; F. Besi; C. Cantoni; Franco Locatelli; P. Vacca; L. Moretta

doi:10.3389/fimmu.2019.00957

Human CAR NK cells: A new non-viral method allowing high efficient transfection and strong tumor cell killing

T. Ingegnere
, F. R. Mariotti
, A. Pelosi
, C. Quintarelli
, Angelis B. De
, N. Tumino
, F. Besi
, C. Cantoni
, Franco Locatelli
, P. Vacca
, L. Moretta^*

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

CAR-NK cells may represent a valuable tool, complementary to CART cells, in adoptive immunotherapy of leukemia and solid tumors. However, gene transfer to human NK cells is a challenging task, particularly with non-virus-based techniques. Here, we describe a new procedure allowing efficient electroporation-based transfection of plasmid DNA, including CAR and CCR7 genes, in resting or cytokine-expanded human NK cell populations and NK-92 cell line. This procedure may offer a suitable platform for a safe and effective use of CAR-NK cells in adoptive immunotherapy of cancer.

Lingua originale	Inglese
pagine (da-a)	1-10
Numero di pagine	10
Rivista	Frontiers in Immunology
Volume	10
Numero di pubblicazione	APR
DOI	https://doi.org/10.3389/fimmu.2019.00957
Stato di pubblicazione	Pubblicato - 2019

All Science Journal Classification (ASJC) codes

Immunologia e Allergia
Immunologia

Keywords

Adoptive immunotherapy
Chemokine receptors
Chimeric Antigen Receptors
Electroporation
NK cells

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.3389/fimmu.2019.00957

Altri file e collegamenti

Cita questo

@article{51a2484b424f4ea39ed714e1d869b43c,

title = "Human CAR NK cells: A new non-viral method allowing high efficient transfection and strong tumor cell killing",

abstract = "CAR-NK cells may represent a valuable tool, complementary to CART cells, in adoptive immunotherapy of leukemia and solid tumors. However, gene transfer to human NK cells is a challenging task, particularly with non-virus-based techniques. Here, we describe a new procedure allowing efficient electroporation-based transfection of plasmid DNA, including CAR and CCR7 genes, in resting or cytokine-expanded human NK cell populations and NK-92 cell line. This procedure may offer a suitable platform for a safe and effective use of CAR-NK cells in adoptive immunotherapy of cancer.",

keywords = "Adoptive immunotherapy, Chemokine receptors, Chimeric Antigen Receptors, Electroporation, NK cells, Adoptive immunotherapy, Chemokine receptors, Chimeric Antigen Receptors, Electroporation, NK cells",

author = "T. Ingegnere and Mariotti, \{F. R.\} and A. Pelosi and C. Quintarelli and De, \{Angelis B.\} and N. Tumino and F. Besi and C. Cantoni and Franco Locatelli and P. Vacca and L. Moretta",

year = "2019",

doi = "10.3389/fimmu.2019.00957",

language = "English",

volume = "10",

pages = "1--10",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media SA",

number = "APR",

}

TY - JOUR

T1 - Human CAR NK cells: A new non-viral method allowing high efficient transfection and strong tumor cell killing

AU - Ingegnere, T.

AU - Mariotti, F. R.

AU - Pelosi, A.

AU - Quintarelli, C.

AU - De, Angelis B.

AU - Tumino, N.

AU - Besi, F.

AU - Cantoni, C.

AU - Locatelli, Franco

AU - Vacca, P.

AU - Moretta, L.

PY - 2019

Y1 - 2019

N2 - CAR-NK cells may represent a valuable tool, complementary to CART cells, in adoptive immunotherapy of leukemia and solid tumors. However, gene transfer to human NK cells is a challenging task, particularly with non-virus-based techniques. Here, we describe a new procedure allowing efficient electroporation-based transfection of plasmid DNA, including CAR and CCR7 genes, in resting or cytokine-expanded human NK cell populations and NK-92 cell line. This procedure may offer a suitable platform for a safe and effective use of CAR-NK cells in adoptive immunotherapy of cancer.

AB - CAR-NK cells may represent a valuable tool, complementary to CART cells, in adoptive immunotherapy of leukemia and solid tumors. However, gene transfer to human NK cells is a challenging task, particularly with non-virus-based techniques. Here, we describe a new procedure allowing efficient electroporation-based transfection of plasmid DNA, including CAR and CCR7 genes, in resting or cytokine-expanded human NK cell populations and NK-92 cell line. This procedure may offer a suitable platform for a safe and effective use of CAR-NK cells in adoptive immunotherapy of cancer.

KW - Adoptive immunotherapy

KW - Chemokine receptors

KW - Chimeric Antigen Receptors

KW - Electroporation

KW - NK cells

KW - Adoptive immunotherapy

KW - Chemokine receptors

KW - Chimeric Antigen Receptors

KW - Electroporation

KW - NK cells

UR - https://publicatt.unicatt.it/handle/10807/229474

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85066468833&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066468833&origin=inward

U2 - 10.3389/fimmu.2019.00957

DO - 10.3389/fimmu.2019.00957

M3 - Article

SN - 1664-3224

VL - 10

SP - 1

EP - 10

JO - Frontiers in Immunology

JF - Frontiers in Immunology

IS - APR

ER -

Human CAR NK cells: A new non-viral method allowing high efficient transfection and strong tumor cell killing

Abstract

All Science Journal Classification (ASJC) codes

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo